Literature DB >> 31712860

Identification of Gene Mutations in Primary Pediatric Cardiomyopathy by Whole Exome Sequencing.

Kitiwan Rojnueangnit1, Boonchu Sirichongkolthong2, Ratthapon Wongwandee2, Thanitchet Khetkham3, Saisuda Noojarern4, Arthaporn Khongkraparn4, Duangrurdee Wattanasirichaigoon4.   

Abstract

Pediatric primary cardiomyopathy is rare but serious, having high mortality; hypertrophic and dilated types are the most common. Its etiology has been mainly considered idiopathic; however, next generation sequencing techniques have revealed nearly half of idiopathic pediatric cases arose from specific genetic mutations. Therefore, our study aimed to identify the genetic causes of primary idiopathic cardiomyopathy. Newborns to 15-year old patients with this condition were recruited between March 2016 and May 2017 at Thammasat University Hospital. Complete patient history and physical examination data were collected by a geneticist with cardiac examinations and echocardiograms by pediatric cardiologists. Whole exome sequencing was performed for all. Of the 12 patients enrolled, 5 cases were dilated type and 7 hypertrophic. Two with dilated type were excluded during follow-up as cause was determined (hypocalcemia and pacemaker induced). A list of 118 genes for cardiomyopathy was analyzed in the remaining 10 cases. Pathogenic and likely pathogenic mutations were identified in 5 patients: HRAS, PTPN11, SOS1, FLNC and TXNRD2; half our patients were not actually idiopathic. Despite its high cost, genetic testing is useful for determining familial risk as well as predicting patient cardiomyopathy progress.

Entities:  

Keywords:  Mutations; Pediatric; Primary cardiomyopathy; Whole exome sequencing

Mesh:

Year:  2019        PMID: 31712860     DOI: 10.1007/s00246-019-02240-x

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  38 in total

1.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal:  J Thorac Cardiovasc Surg       Date:  2011-12       Impact factor: 5.209

2.  Genetic Testing in Pediatric Cardiomyopathy.

Authors:  Chalani D Ellepola; Linda M Knight; Peter Fischbach; Shriprasad R Deshpande
Journal:  Pediatr Cardiol       Date:  2017-11-29       Impact factor: 1.655

3.  Incidence, causes, and outcomes of dilated cardiomyopathy in children.

Authors:  Jeffrey A Towbin; April M Lowe; Steven D Colan; Lynn A Sleeper; E John Orav; Sarah Clunie; Jane Messere; Gerald F Cox; Paul R Lurie; Daphne Hsu; Charles Canter; James D Wilkinson; Steven E Lipshultz
Journal:  JAMA       Date:  2006-10-18       Impact factor: 56.272

Review 4.  Pediatric Cardiomyopathies.

Authors:  Teresa M Lee; Daphne T Hsu; Paul Kantor; Jeffrey A Towbin; Stephanie M Ware; Steven D Colan; Wendy K Chung; John L Jefferies; Joseph W Rossano; Chesney D Castleberry; Linda J Addonizio; Ashwin K Lal; Jacqueline M Lamour; Erin M Miller; Philip T Thrush; Jason D Czachor; Hiedy Razoky; Ashley Hill; Steven E Lipshultz
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

5.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

Authors:  P Richardson; W McKenna; M Bristow; B Maisch; B Mautner; J O'Connell; E Olsen; G Thiene; J Goodwin; I Gyarfas; I Martin; P Nordet
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

6.  A novel mutation in the PTPN11 gene in a patient with Noonan syndrome and rapidly progressive hypertrophic cardiomyopathy.

Authors:  Kunihiko Takahashi; Shigetoyo Kogaki; Shunji Kurotobi; Sayaka Nasuno; Makiko Ohta; Hitomi Okabe; Kazuko Wada; Norio Sakai; Masako Taniike; Keiichi Ozono
Journal:  Eur J Pediatr       Date:  2005-05-12       Impact factor: 3.183

7.  Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies.

Authors:  Martín F Ortiz-Genga; Sofía Cuenca; Matteo Dal Ferro; Esther Zorio; Ricardo Salgado-Aranda; Vicente Climent; Laura Padrón-Barthe; Iria Duro-Aguado; Juan Jiménez-Jáimez; Víctor M Hidalgo-Olivares; Enrique García-Campo; Chiara Lanzillo; M Paz Suárez-Mier; Hagith Yonath; Sonia Marcos-Alonso; Juan P Ochoa; José L Santomé; Diego García-Giustiniani; Jorge L Rodríguez-Garrido; Fernando Domínguez; Marco Merlo; Julián Palomino; María L Peña; Juan P Trujillo; Alicia Martín-Vila; Davide Stolfo; Pilar Molina; Enrique Lara-Pezzi; Francisco E Calvo-Iglesias; Eyal Nof; Leonardo Calò; Roberto Barriales-Villa; Juan R Gimeno-Blanes; Michael Arad; Pablo García-Pavía; Lorenzo Monserrat
Journal:  J Am Coll Cardiol       Date:  2016-12-06       Impact factor: 24.094

8.  The epidemiology of childhood cardiomyopathy in Australia.

Authors:  Alan W Nugent; Piers E F Daubeney; Patty Chondros; John B Carlin; Michael Cheung; Lynette C Wilkinson; Andrew M Davis; Stephen G Kahler; C W Chow; James L Wilkinson; Robert G Weintraub
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

9.  Mutations in the mitochondrial thioredoxin reductase gene TXNRD2 cause dilated cardiomyopathy.

Authors:  Dirk Sibbing; Arne Pfeufer; Tamara Perisic; Alexander M Mannes; Karin Fritz-Wolf; Sarah Unwin; Moritz F Sinner; Christian Gieger; Christian Johannes Gloeckner; Heinz-Erich Wichmann; Elisabeth Kremmer; Zasie Schäfer; Axel Walch; Martin Hinterseer; Michael Näbauer; Stefan Kääb; Adnan Kastrati; Albert Schömig; Thomas Meitinger; Georg W Bornkamm; Marcus Conrad; Nicolas von Beckerath
Journal:  Eur Heart J       Date:  2011-01-18       Impact factor: 29.983

10.  Diagnostic Yield of Whole Exome Sequencing in Pediatric Dilated Cardiomyopathy.

Authors:  Pamela A Long; Jared M Evans; Timothy M Olson
Journal:  J Cardiovasc Dev Dis       Date:  2017-08-08
View more
  3 in total

1.  Whole-Exome Sequencing in Patients Affected by Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Reveals New Variants Potentially Contributing to the Phenotype.

Authors:  Dora Janeth Fonseca; Adrien Morel; Kevin Llinás-Caballero; David Bolívar-Salazar; Paul Laissue
Journal:  Pharmgenomics Pers Med       Date:  2021-03-01

Review 2.  Pathogenic Variants in Selenoproteins and Selenocysteine Biosynthesis Machinery.

Authors:  Didac Santesmasses; Vadim N Gladyshev
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

3.  Rare clinical phenotype of filaminopathy presenting as restrictive cardiomyopathy and myopathy in childhood.

Authors:  A Muravyev; T Vershinina; P Tesner; G Sjoberg; Yu Fomicheva; N Novák Čajbiková; A Kozyreva; S Zhuk; E Mamaeva; S Tarnovskaya; J Jornholt; P Sokolnikova; T Pervunina; E Vasichkina; T Sejersen; A Kostareva
Journal:  Orphanet J Rare Dis       Date:  2022-09-14       Impact factor: 4.303

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.